Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Resveratrol M010090

 

CASRN: 501-36-0

Formula: C14-H12-O3

Synonyms/Common Names

  • 1,3-Benzenediol,5-(2-(4-hydroxyphenyl)ethenyl)-,(E)-
  • NSC 327430
  • 3,4',5-Stilbenetriol
  • 3,4',5-Trihydroxystilbene

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 2 weeks (Gavage)  (C20323)  Completed 
    • Rats: F344/NTac; Mice: B6C3F1
    • Dose: Rats and mice: 0, 78(R), 156, 312, 625, 1250, or 2500(M) mg/kg; 5/sex/species.
  • 13 weeks (Gavage)  (C20323)  Completed 
    • Rats: Wistar Han; Mice: B6C3F1
    • Dose: Rats: 0, 78, 156, 312.5, 625, or 1250 mg/kg; 10/sex/dose; Mice: 0, 156, 312, 625, 1250, or 2500 mg/kg; 10/sex/dose.

Long-Term Carcinogenicity

  • 2 years (Gavage)  (C20323)  Data in Review 
    • Rats: Harlan Sprague-Dawley; Mice: B6C3F1
    • Dose: Rats: 0, 312.5, 625, or 1250 mg/kg; 60/sex/dose @ 0 or 1250 mg/kg and 50/sex/dose @ 625 or 312.5; Mice: 0, 625, 1250, or 2500 mg/kg.

Modified One-Generation

  • Developmental Toxicity (Gavage)  (MOG01090)  On Test 
    • Developmental toxicity
    • Rats: Harlan Sprague-Dawley
    • Dose: 0, 312.5, 625, or 1250 mg/kg.
  • F0 Generation (Gavage)  (MOG01090)  On Test 
    • Rats: Harlan Sprague-Dawley
    • Dose: 0, 312.5, 625, or 1250 mg/kg.
  • Fertility Assessment (Gavage)  (MOG01090)  On Test 
    • Fertility assessment
    • Rats: Harlan Sprague-Dawley
    • Dose: 0, 312.5, 625, or 1250 mg/kg.

Special Studies

  • Toxicokinetic Study (Gavage)  (K01090B)  Completed 
    • Pilot study
    • Citation: Resveratrol Preliminary Toxicokinetic Study Preliminary Toxicokinetic Study of Reservatrol Administered by Gavage to Male and Female Wistar Han Rats. March 22, 2013.
    • Male and Female Rats: Wistar Han
    • Dose: Dose adult (13 ± 2 weeks) male and female Wistar-Han rats with resveratrol by gavage at 78 mg/kg or 1250 mg/kg body weight (7 per dose group). Rats will be fed NTP 2000 diet. Dose timed-mated pregnant female Wistar-Han rats on gestation day 11-18 with resveratrol by gavage at 78 mg/kg or 1250 mg/kg body weight (6 per dose group). Dose Wistar-Han dams starting at gd 18 through pnd 4 with resveratrol at 78 mg/kg or 1250 mg/kg body weight (8 dams per dose group) pups on postnatal day 4.Pilot study developed to generate plasma and tissue samples..
  • Toxicokinetic Study (Gavage; Intravenous)  (K01090C)  On Test 
    • toxicokinetic studies of trans-resveratrol
    • Male and Female Rats: Harlan Sprague-Dawley; Male and Female Mice: B6C3F1/N; Male and Female Rats: Harlan Sprague-Dawley; Male and Female Mice: B6C3F1/N
    • Dose: 0, 312.5, 625, and 1250 mg/kg. 10 mg/kg. 625, 1250, 2500 mg/kg.

Genetic Toxicology

  • Micronucleus  (G01090B)  Completed 
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative 
  • Micronucleus  (G01090)  Completed 
    • Rats: Wistar Han
    • Male Negative 
    • Female Negative 
  • Salmonella  (A12955)  Completed 
    •  Negative 

Organ Systems Toxicity

  • 180 days Immunotoxicity (Gavage)  (I01090)  Data in Review 
    • Assessment of the Ability of trans-Resveratrol to Modulate Type 1 Diabetes in Female Non-Obese Diabetic Mice
    • Female Mice: NOD/MrKTac
    • Dose: 0, 125, 250, 500, 1000 or 2000 mg/kg/day.
  • 28 days Immunotoxicity (Gavage)  (IMM20704)  Data in Review 
    • Male Mice: B6C3F1
    • Dose: 0, 156, 312, 625, 1250, OR 2500 MG/KG/DAY.